The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 16, 2025 for Aayush Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Midcap 150 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aayush Agrawal, trustee of the Aayush Agrawal Trust and promoter of Ajanta Pharma, has created a pledge on 2,60,000 shares (0.21% of total share capital) on June 9, 2025. The reason given is a change in lender, with the new pledge favouring Aditya Birla Money Ltd. After this event, the trust's total encumbered shares stand at 58,35,002 (4.67% of share capital), up from 55,75,002 earlier. The trust's overall promoter holding remains unchanged at 1,41,12,924 shares (11.30%). The disclosure was filed with BSE and NSE on June 16, 2025 under SEBI SAST Regulations.
This is a routine reshuffling of pledged shares between lenders, not a fresh increase in pledged exposure. Shareholders are unlikely to see a meaningful impact on stock price, though any sharp rise in pledged promoter shares warrants monitoring.